ANDA 62760, held by Teva. Cephalexin.
As of Nov 13, 2026, ANDA 62760 (Cephalexin), held by Teva, was first approved by FDA on Apr 24, 1987, with 20 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 24, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| CephalexinEQ 250MG BASE ยท capsule;oral | Cephalexin | Discontinued |
| Sep 11, 2000 | Supplement 29Manufacturing | Approved | None posted |
| Feb 23, 2000 | Supplement 27Manufacturing | Approved | None posted |
| Feb 23, 2000 | Supplement 26Manufacturing | Approved | None posted |
| Feb 23, 2000 | Supplement 25Manufacturing | Approved | None posted |
| Mar 17, 1998 | Supplement 24Manufacturing | Approved | None posted |
| Jul 16, 1996 | Supplement 23Labeling | Approved | None posted |
| Jul 18, 1994 | Supplement 22Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 21Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 20Manufacturing | Approved | None posted |
| Jun 23, 1994 | Supplement 19Manufacturing | Approved | None posted |
| Dec 22, 1993 | Supplement 17Manufacturing | Approved | None posted |
| Dec 7, 1993 | Supplement 18Labeling | Approved | None posted |
| Aug 13, 1993 | Supplement 16Labeling | Approved | None posted |
| May 26, 1993 | Supplement 14Manufacturing | Approved | None posted |
| May 26, 1993 | Supplement 13Manufacturing | Approved | None posted |
| Jul 30, 1992 | Supplement 12Labeling | Approved | None posted |
| Mar 24, 1992 | Supplement 10Manufacturing | Approved | None posted |
| Feb 27, 1992 | Supplement 11Labeling | Approved | None posted |
| Mar 10, 1988 | Supplement 6Manufacturing | Approved | None posted |
| Feb 25, 1988 | Supplement 8Manufacturing | Approved | None posted |
| Apr 24, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters